EYA4 exerts its tumor-suppressive functions mainly through deactivation of β-catenin/inhibitor of DNA binding 2 (ID2) cascade7, raising the possibility that TRIM69 might thwart the EYA4-driven deactivation of β-catenin/ID2 cascade. The gene discussed is EYA4; the disease is neoplasm.